Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 55 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Fertilization in Vitro [Clear All Filters]
Is in vitro fertilization an indication for fetal echocardiography?.
Fertil Steril. 116(3), 676-677.
(2021).
(2019).
(2019).
Follicular flushing during oocyte retrieval in assisted reproductive techniques..
Cochrane Database Syst Rev. 4, CD004634.
(2018). Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome..
Ultrasound Obstet Gynecol. 51(1), 126-133.
(2018). Blastocyst utilization rates after continuous culture in two commercial single-step media: a prospective randomized study with sibling oocytes..
J Assist Reprod Genet. 34(10), 1377-1383.
(2017). Hydrosalpinx: Tubal surgery or in vitro fertilisation? An everlasting dilemma nowadays; a narrative review..
J Obstet Gynaecol. 37(5), 550-556.
(2017). Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles..
Hum Reprod. 31(8), 1859-65.
(2016). High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta-analysis..
Ultrasound Obstet Gynecol. 48(5), 556-565.
(2016). Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial..
Lancet. 387(10038), 2614-2621.
(2016). The impact of thyroid autoimmunity on IVF/ICSI outcome: re-evaluation of the findings..
Hum Reprod Update. 22(6), 791.
(2016). Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis..
Ultrasound Obstet Gynecol. 48(4), 434-445.
(2016). Thyroid function and IVF outcome: when to investigate and when to intervene?.
Curr Opin Obstet Gynecol. 28(3), 191-7.
(2016).
(2015).
(2015).
Association of TSH concentrations and thyroid autoimmunity with IVF outcome in women with TSH concentrations within normal adult range..
Gynecol Obstet Invest. 77(2), 84-8.
(2014). ESHRE task force on ethics and Law22: preimplantation genetic diagnosis..
Hum Reprod. 29(8), 1610-7.
(2014). Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET..
Arch Gynecol Obstet. 290(6), 1249-53.
(2014). Reply of the authors..
Fertil Steril. 101(1), e5-6.
(2014). Thyroid cancer after in vitro fertilization: a retrospective, non-consecutive case-series analysis..
Gynecol Endocrinol. 30(8), 569-72.
(2014). Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles..
Fertil Steril. 100(3), 742-7.
(2013). "Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study"..
J Assist Reprod Genet. 30(10), 1341-5.
(2013). GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial..
Eur J Obstet Gynecol Reprod Biol. 166(1), 43-6.
(2013). GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients..
Hum Reprod. 28(9), 2511-21.
(2013). Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS..
Hum Reprod. 28(7), 1929-42.
(2013).